Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18009071 | PROCESS FOR PRODUCING CARRIER PARTICLES FOR THE CULTIVATION OF BIOLOGICAL CELLS, CARRIER PARTICLES AND THEIR USE | Final Rejection | Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e. V. |
| 17774834 | EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS | Non-Final OA | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 18246087 | NOVEL ENHANCED BASE EDITING OR REVISING FUSION PROTEIN AND USE THEREOF | Final Rejection | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 17632063 | TARGETED GENE THERAPY TO TREAT NEUROLOGICAL DISEASES | Non-Final OA | Cornell University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy